Results 171 to 180 of about 175,789 (362)

Challenges Posed by Adults With Repaired Congenital Heart Disease

, 2001
Joseph K. Perloff, Carole A. Warnes
openalex   +1 more source

Comparison of health related quality of life with cardiopulmonary exercise testing in adolescents and adults with congenital heart disease [PDF]

, 2005
Alfred Hager
openalex   +1 more source

Coordinated expression of BMP10/ALK1/endoglin—proteins that drive embryonic cardiac and vascular morphogenesis—in patients with heart failure: The EMPEROR Program

European Journal of Heart Failure, EarlyView.
Aims Bone morphogenetic protein 10 (BMP10), activin receptor‐like kinase 1 (ALK1) and endoglin form a single transforming growth factor‐β family signalling complex that is the principal driver of cardiac and vascular morphogenesis and maturation during hypoxic embryonic development. These proteins are down‐regulated with the onset of normoxia at birth,
Milton Packer, Javed Butler, João Pedro Ferreira, Tariq Jamal Siddiqi, James L. Januzzi Jr, Naveed Sattar, Sandra González Maldonado, Marina Panova‐Noeva, Jürgen H. Prochaska, Mikhail Sumin, Serge Masson, Stuart J. Pocock, Gerasimos Filippatos, Stefan D. Anker, Faiez Zannad   +14 more
wiley   +1 more source

The spectrum of adult congenital heart disease in Europe: morbidity and mortality in a 5 year follow-up period [PDF]

, 2005
Peter Engelfriet, Eric Boersma, Erwin Oechslin, Jan G.P. Tijssen, Michael Α. Gatzoulis, Ulf Thilén, Harald Kaemmerer, Philip Moons, Folkert J. Meijboom, Jana Popelová, Valérie Laforest, Rafael Hirsch, Luciano Daliento, Erik Thaulow, Barbara J.M. Mulder   +14 more
openalex   +1 more source

Contactless Conductivity Detection for Capillary Electrophoresis—Developments From 2020 to 2024

ELECTROPHORESIS, EarlyView.
ABSTRACT The review covering the development of capillary electrophoresis with capacitively coupled contactless conductivity detection from 2020 to 2024 is the latest in a series going back to 2004. The article considers applications employing conventional capillaries and planar lab‐on‐chip devices as well as fundamental and technical developments of ...
Peter C. Hauser, Pavel Kubáň
wiley   +1 more source

Congenital Heart Disease in Adults: Second of Two Parts

, 2001
NULL AUTHOR_ID
openalex   +1 more source

Is it safe to perform cardiac catheterizations on adults with congenital heart disease in a pediatric catheterization laboratory? [PDF]

, 2005
Swati Garekar, Melissa M. Paules, Surendranath Veeram Reddy, Daniel R. Turner, Sanjeev Sanjeev, Joshua Wynne, Michael L. Epstein, Peter P. Karpawich, Robert D. Ross, Thomas J. Forbes   +9 more
openalex   +1 more source

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)

Environmental and Molecular Mutagenesis, EarlyView.
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons, Marc A. Beal, Kerry L. Dearfield, George R. Douglas, Min Gi, B. Bhaskar Gollapudi, Robert H. Heflich, Katsuyoshi Horibata, Michelle Kenyon, Alexandra S. Long, David P. Lovell, Anthony M. Lynch, Meagan B. Myers, Stefan Pfuhler, Alisa Vespa, Andreas Zeller, George E. Johnson, Paul A. White   +17 more
wiley   +1 more source

Leadless atrioventricular synchronous pacing in Eisenmenger syndrome

HeartRhythm Case Reports, 2021
Paul Khairy, MD, PhD, Blandine Mondésert, MD, François-Pierre Mongeon, MD, SM, Nancy Poirier, MD, Bernard Thibault, MD, FHRS   +4 more
doaj  

1423 Sexual Functioning in Adults with Congenital Heart Disease [PDF]

, 2005
Philip Moons, Kristien Van Deyk, Kristel Marquet, Leentje De Bleser, Werner Budts, Sabina De Geest   +5 more
openalex   +1 more source